With the current nil-rate threshold for inheritance tax being frozen at £325,000 until 2028, many investors will be wondering how they can reduce tax liabilities for their estate when they die.In the 2021-22 tax year, inheritance tax receipts jumped 14% to a record £6.1 billion as more people's estates topped the threshold, yet according to a survey by estate planning firm Time Investments only

Commercial stage biopharmaceutical company Hutchmed (HCM:AIM) said its pancreatic tumor drug surufatinib had failed to be approved by the US FDA (Food & Drug Administration), sending the shares 15% lower to 208p on Tuesday.The FDA originally accepted the company's new drug application submission on 30 June 2020 which was based on two positive late stage trials in China along with a bridging study

One of AIM's biggest success stories is finally packing its bags and moving to London's Main Market. Fashion retailer ASOS (ASC:AIM) will switch markets by the end of February and this event could potentially see a few other businesses do the same.AIM was set up as a market for young companies to access capital markets and tap up investors for cash to help them grow, as well as use their shares to

Rising inflation expectations means that growth-hungry investors will need to be increasingly discerning and disciplined in terms of their stock picking in the months ahead.One sensible solution is to invest in a fund where the manager has pedigree in backing dynamic growth companies without overpaying to own the shares. Step forward Mark Slater, who has managed Slater Growth Fund (B7T0G90) since

London's FTSE 100 was down 0.9% to 7,092.26 points by noon on Friday with some index heavyweights under pressure, investors factoring in guidance from the US Federal Reserve suggesting rate hikes will come in 2023 and with UK retail sales figures for May coming in below expectations.Retail sales fell by 1.4% between April and May as people chose to visit reopened bars and restaurants instead of bu

Leading UK shares were marked lower in early trading on Friday as retail sales figures for May came in below expectations.Retail sales fell by 1.4% between April and May as people chose to visit reopened bars and restaurants instead of buying food at supermarkets. The Office for National Statistics said sales fell most significantly at food stores as consumers took advantage of Covid restrictions

The appeal of a growth company is easy to understand - when we put our money into a business which we expect to grow rapidly we can imagine the worth of our investment growing fast too.Many of today's largest companies were once small or medium-sized operations which have expanded their business by targeting a buoyant market or identifying a particularly profitable niche.And growth as an investmen

FTSE 100 pharmaceuticals firm AstraZeneca (AZN) reveals combining the use of Imfinzi and tremelimumab to treat stage IV non-small cell lung cancer (NSCLC) did not improve overall survival for patients in the Phase III MYSTIC trial.Essentially, this means patients treated with Imfinzi by itself and in combination with tremelimumab were not significantly more likely to survive compared to the standa

Many investors are fascinated by how certain investors got to be so famous, searching for the special formula that made the likes of Warren Buffett and Philip Fisher so rich. Well now's your chance to mimic their approach and apply their proven methodology to today's market.We show you two ways to deploy their process. The first uses stock screeners built using Stockopedia's interpretation of how

So far this month familiar investments trusts are proving popular with retail investors. The top three buys are Scottish Investment Trust (SCIN), Scottish Mortgage (SMT) and City of London (CTY), according to data provided by AJ Bell's YouInvest platform.Others in the top 10 include Edinburgh Investment (EDIN), Witan Investment Trust (WTAN) and Fidelity China Special Situations (FCSS).A full list

MARKET CAP: £1BN & ABOVE IQE +318%To call IQE's (IQE:AIM) share price run this year remarkable still understates the performance. At one stage last month the stock closed at 178.75p. The share price began the year trading at 37.75p.So why has it had an amazing run? Unconfirmed rumours that IQE's vertical-cavity surface-emitting laser (VCSEL) technology is being used in Apple's latest iPhone are l

WHAT IS A GROWTH STOCK?Growth, or the perception of it, is arguably the biggest driver of share prices.The Organisation for Economic Co-operation and Development (OECD) defines a growth business as a company of 10 or more employees that grows revenues by an average of more than 20% per year for three consecutive years.'That sounds like a good enough definition,' says Lorne Daniel, an analyst at br

Size matters. The UK's largest stocks are typically easy to buy and sell, hold dominant market positions, are often diversified across several different areas and typically generate plenty of cash which can be returned to shareholders through generous dividends.'Economies of scale' also make it cheaper for these market giants to buy in goods and services and allow them to manufacture their own pro

Takeover activity among FTSE 250 stocks dominates the news agenda at the start of the new trading week.Housebuilder Bovis Homes (BVS) has rejected two takeover approaches from Redrow (RDW) and Galliford Try (GFD).The Redrow proposal is structured as a cash and shares deal and values Bovis at a discount to its closing share price last Friday. Galliford wants an all-share merger with its shareholder

You may be surprised to learn that eight companies on the AIM market are now worth more than £1bn each. The top company, ASOS (ASC:AIM) is even big enough to be part of the FTSE 100, should it ever decide to switch its listing to London's Main Market.AIM is considered to be a market for junior companies, providing a platform for them to grow.We discuss the strengths of the AIM market in the new i

Few industries have stronger investment drivers than pharmaceuticals and biotechnology. The rewards can be significant for investors who back the company that discovers the next wonder drug. For example, US outfit AbbVie (ABBV:NYSE) collected $12.5 billion in revenue in 2014 from Humira, a treatment for inflammatory conditions such as rheumatoid arthritis.The risks are proportionately high, so we

In some ways, investment styles are a bit like the pick 'n' mix section of a well-stocked sweet shop. Cola bottles will suit some tastes, others may prefer cola cubes; pear drops, rhubarb and custard or humbugs could prove the fancy of a completely different group. So it is with investment, every investor must make their own choices based on their own feelings towards risk, time frame and an assor

London stocks end the week modestly in the red in early trade on Friday as investors continue to digest a worse-than-forecast slowdown in US economic growth in the third quarter, while also looking ahead to Eurozone inflation figures. The benchmark FTSE 100 index drifts mid-single digits to 6,391, although midcaps do better, the FTSE 250 index posting marginal rises of around 12 points to 17,128.I

Shares in London open higher in early trade on Friday following strong gains last night in the US and earlier today in Asia, and supporting by a modest rally in several construction-based firms. The benchmark FTSE 100 index is up around 40 points, or 0.6%, at 6,415, with gains being made right across the midcap, small cap and AIM markets.In corporate news, another headline-grabbing cyber security

UK shares make early gains in trading on Tuesday despite another hefty sell-off in China and a mixed bag of corporate announcements. The FTSE 100 index rallies around 30 points higher, about 0.4%, to 6,53, with midcaps and the wider FTSE All Share posting similar gains.TV broadcaster ITV (ITV) rises 2.4% 270.1p as it delivers a strong financial performance for the first half of the year, with an i